Anti-thrombotics and their impact on inpatient epistaxis management: a tertiary centre experience

[1]  A. Tognarelli,et al.  Role of Hypertension and Other Clinical Variables in Prognostication of Patients Presenting to the Emergency Department With Major Bleeding Events , 2018, Critical pathways in cardiology.

[2]  T. Tikka,et al.  Patterns of hospital admission in 54 501 patients with epistaxis over a 20‐year period in Scotland, UK , 2018, Clinical otolaryngology : official journal of ENT-UK ; official journal of Netherlands Society for Oto-Rhino-Laryngology & Cervico-Facial Surgery.

[3]  A. Exadaktylos,et al.  Epistaxis in anticoagulated patients: Fewer hospital admissions and shorter hospital stays on rivaroxaban compared to phenprocoumon , 2018, Clinical otolaryngology : official journal of ENT-UK ; official journal of Netherlands Society for Oto-Rhino-Laryngology & Cervico-Facial Surgery.

[4]  M. Smith,et al.  Haematological factors in the management of adult epistaxis: systematic review , 2017, The Journal of Laryngology & Otology.

[5]  C. Philpott,et al.  Initial assessment in the management of adult epistaxis: systematic review , 2017, The Journal of Laryngology & Otology.

[6]  K. Stevens,et al.  Epistaxis 2016: national audit of management , 2017, The Journal of Laryngology & Otology.

[7]  L. Huiart,et al.  Trends in the prescription of novel oral anticoagulants in UK primary care , 2017, British journal of clinical pharmacology.

[8]  C. Moura,et al.  Risk factors for the occurrence of epistaxis: Prospective study. , 2017, Auris, nasus, larynx.

[9]  C. Hopkins,et al.  Can trainees design and deliver a national audit of epistaxis management? A pilot of a secure web-based audit tool and research trainee collaboratives , 2017, The Journal of Laryngology & Otology.

[10]  P. Daniels.  Peri-procedural management of patients taking oral anticoagulants , 2015, BMJ : British Medical Journal.

[11]  A. Iloreta,et al.  Cost of management in epistaxis admission: Impact of patient and hospital characteristics , 2015, The Laryngoscope.

[12]  P. Chatrath,et al.  A multi-centre audit of epistaxis management in England: is there a case for a national review of practice? , 2015, The Journal of Laryngology & Otology.

[13]  D. Kikidis,et al.  Is epistaxis associated with arterial hypertension? A systematic review of the literature , 2014, European Archives of Oto-Rhino-Laryngology.

[14]  Jennifer A. Villwock,et al.  Recent trends in epistaxis management in the United States: 2008-2010. , 2013, JAMA otolaryngology-- head & neck surgery.

[15]  J. Jeong,et al.  Epistaxis in patients taking oral anticoagulant and antiplatelet medication: prospective cohort study , 2010, The Journal of Laryngology & Otology.

[16]  J. Rainsbury,et al.  Clopidogrel versus low‐dose aspirin as risk factors for epistaxis , 2009, Clinical otolaryngology : official journal of ENT-UK ; official journal of Netherlands Society for Oto-Rhino-Laryngology & Cervico-Facial Surgery.

[17]  Clare Taylor.  Epistaxis , 2009, The New England journal of medicine.

[18]  N. Jones,et al.  Guidelines for the management of idiopathic epistaxis in adults: how we do it , 2008, Clinical otolaryngology : official journal of ENT-UK ; official journal of Netherlands Society for Oto-Rhino-Laryngology & Cervico-Facial Surgery.

[19]  W. Jerjes,et al.  A change in UK epistaxis management , 2008, European Archives of Oto-Rhino-Laryngology.

[20]  T. Walker,et al.  The epidemiology and chronobiology of epistaxis: an investigation of Scottish hospital admissions 1995–2004 , 2007, Clinical Otolaryngology.

[21]  W. Jerjes,et al.  The role of surgical audit in improving patient management; nasal haemorrhage: an audit study , 2007, BMC surgery.

[22]  G. Worley,et al.  Do all epistaxis patients with a nasal pack need admission? A retrospective study of 116 patients managed in accident and emergency according to a peer reviewed protocol. , 2007, The Journal of laryngology and otology.

[23]  C. Hobbs,et al.  Epistaxis: an update on current management , 2005, Postgraduate Medical Journal.

[24]  Josie M. M. Evans,et al.  Aspirin, Nonsteroidal Anti-Inflammatory Drugs, and Epistaxis , 1998, The Annals of otology, rhinology, and laryngology.

[25]  D. G. John,et al.  Warfarin and epistaxis: should warfarin always be discontinued? , 1997, Clinical otolaryngology and allied sciences.

[26]  C. Maynard,et al.  Warfarin and epistaxis — a case controlled study , 1993, The Journal of Laryngology & Otology.

[27]  W. Jerjes,et al.  A change in UK epistaxis management , 2008, European Archives of Oto-Rhino-Laryngology.

[28]  Barton Rt.  Management of epistaxis. , 1956, Medical arts and sciences.